Article Details
Retrieved on: 2021-10-11 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here